Windtree
WINT

股本结构

单位：万股
公告日期 2025-08-19 2025-07-30 2025-07-10 2025-08-19 2025-05-15 2025-05-15
证券总股本 2933.42 2865.88 1157.41 924.80 366.13 355.60
普通股本 2933.42 2865.88 1157.41 924.80 366.13 355.60
优先股 未披露 未披露 未披露 0.43 0.60 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-08-19 2025-07-23 2025-07-09 2025-06-30 2025-05-15 2025-03-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-08-19 2933.42 未披露 定期报告 2025-08-19
2025-07-30 2865.88 未披露 定期报告 2025-07-23
2025-07-10 1157.41 未披露 定期报告 2025-07-09
2025-08-19 924.80 0.43
更多>>
From March 31, 2025 to June 30, 2025 Exercise of common stock warrants Series C preferred stock conversions Issuance of common stock, ELOC
2025-06-30
2025-05-15 366.13 0.60 定期报告 2025-05-15
2025-04-23 365.23 0.27 定期报告 2025-04-21
2025-05-15 355.60 0.28
更多>>
From December 31, 2024 to March 31, 2025 Series C preferred stock conversions Issuance of common stock, ELOC Issuance of common stock, equity consideration in debt extinguishment Exercise of common stock warrants
2025-03-31
2025-02-18 74.93 未披露
更多>>
a 1-for-50 reverse stock split of the outstanding shares of the Company’s common stock.
2025-02-21
2025-02-14 3746.71 未披露 定期报告 2025-02-13
2025-01-08 1104.88 未披露 定期报告 2024-12-20
2024-11-26 898.98 未披露 定期报告 2024-11-22
2024-10-28 874.61 未披露 定期报告 2024-10-25
2024-10-04 367.97 未披露 定期报告 2024-10-04
2024-11-26 234.04 1.57
更多>>
From June 30, 2024 to September 30, 2024 Issuance of Series C preferred stock for cash proceeds, net of issuance costs of $172 Redemptions of Series C preferred stock Exchange of Series B preferred stock ELOC sales, net of issuance costs of $156 Issuance of Series C preferred stock to extinguish debt Conversions of Series C preferred stock
2024-09-30
2024-09-13 161.07 未披露 定期报告 2024-09-13
2024-09-03 59.19 未披露 定期报告 2024-08-05
2024-07-22 59.17 未披露 定期报告 2024-07-18
2024-08-19 59.19 0.55
更多>>
From March 31, 2024 to June 30, 2024 Reverse split adjustments - fractional share round ups
2024-06-30
2024-05-15 59.19 未披露 定期报告 2024-05-15
2024-04-18 50.00 未披露
更多>>
1-for-18 reverse stock split of its issued and outstanding common stock
2024-04-22
2024-04-18 920.00 未披露 定期报告 2024-04-18
2024-04-16 918.32 未披露 定期报告 2024-04-16
2024-03-12 918.10 未披露 定期报告 2024-02-20
2024-02-14 850.19 未披露 定期报告 2024-02-01
2024-01-16 650.79 未披露 定期报告 2024-01-16
2024-04-16 599.66 未披露
更多>>
From December 31,2022 to December 31,2023 Vesting of restricted stock units Exercise of common stock warrants, net of expenses of $276 Reverse split adjustments - fractional share round ups Issuance of common stock and common stock warrants, net of issuance costs of $1,630 Issuance of common stock, ATM Program, net of issuance costs of $23
2023-12-31
2023-08-07 514.82 未披露 定期报告 2023-06-30
2023-06-30 514.82 未披露 定期报告 2023-06-15
2023-05-19 538.48 未披露 定期报告 2023-05-19
2023-05-01 514.79 未披露 定期报告 2023-04-27
2023-05-15 90.90 未披露
更多>>
From December 31, 2022 to March 31, 2023 Exercise of common stock warrants, net of expenses Vesting of restricted stock units Reverse split adjustments - fractional share round ups Redemption of Series A Preferred Stock
2023-03-31
2023-03-31 90.90 未披露 定期报告 2023-03-30
2023-02-23 87.06 未披露
更多>>
On February 23, 2023, Windtree Therapeutics, Inc. (the “Company”) announced that it intends to effect a reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1 post-split share for every 50 pre-split shares.
2023-02-24
2023-02-23 4353.10 未披露 定期报告 2023-02-22
2022-11-14 3861.01 未披露 定期报告 2022-11-14
2022-11-14 3264.67 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock, ATM Program, net of issuance costs
2022-09-30
2022-08-11 3062.79 未披露 定期报告 2022-08-11
2022-08-11 2940.62 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock, ATM Program, net of issuance costs
2022-06-30
2022-04-29 2940.62 未披露 定期报告 2022-04-29
2022-05-05 2846.93 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock, ATM Program, net of issuance costs
2022-03-31
2022-03-31 2846.93 未披露 定期报告 2022-03-30
2022-03-31 2826.89 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock, ATM Program, net of issuance costs
2021-12-31
2021-11-10 2826.89 未披露 定期报告 2021-11-10
2021-08-05 2670.45 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock, ATM Program
2021-06-30
2021-05-13 2625.71 未披露
更多>>
From December 31, 2020 to March 31, 2021 Issuance of common stock, ATM Program Issuance of common stock and common stock warrants, net of issuance costs
2021-03-31
2021-03-25 2625.71 未披露
更多>>
1.Common stock offered by the company 9,230,500 shares. 2.The number of shares of common stock that will be outstanding after this offering is based on 17,026,565 shares of common stock outstanding as of March 19, 2021.
2021-03-25
2021-03-22 1702.66 未披露 定期报告 2021-03-19
2020-11-16 1692.15 未披露
更多>>
From June 30, 2020 to September 30, 2020 Vesting of restricted stock units Exercise of common stock warrants
2020-09-30
2020-08-14 1688.65 未披露 定期报告 2020-08-13
2020-08-14 1686.87 未披露
更多>>
from March 31, 2020 to June 30, 2020 Issuance of common stock and common stock warrants, net of issuance costs
2020-06-30
2020-05-21 1645.60 未披露
更多>>
1.We are offering 2,758,620 units. Each unit will consist of one share of our common stock and a warrant to purchase one share of our common stock.
2020-05-20
2017-05-15 1030.13 未披露 定期报告 2017-05-11
2017-05-18 973.43 未披露 定期报告 2017-04-30
2017-05-15 959.06 未披露 定期报告 2017-03-31
2017-03-31 943.94 未披露 定期报告 2017-03-23
2017-03-31 872.36 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match
2016-12-31
2016-11-14 847.60 未披露 定期报告 2016-09-30
2016-08-10 830.87 未披露 定期报告 2016-08-05
2016-08-10 829.08 未披露 定期报告 2016-06-30
2016-05-12 823.06 未披露 定期报告 2016-03-31
2016-03-29 819.13 未披露 定期报告 2016-03-15
2016-03-29 819.45 未披露
更多>>
From December 31, 2014 to January 25, 2016 Issuance of common stock, July 2015 financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Stock-based compensation expense The accompanying consolidated financial statements reflect a 1-for-14 reverse split of our common stock and a change in the number of shares of common stock authorized for issuance under our Amended and Restated Certificate of Incorporation, as amended (Certificate of Incorporation), that was approved by our Board of Directors and stockholders and made effective on January 22, 2016.
2016-01-25
2015-12-14 11406.48 未披露 定期报告 2015-12-10
2015-11-05 11206.48 未披露 定期报告 2015-09-30
2015-08-10 11099.99 未披露 定期报告 2015-08-01
2015-08-10 8591.66 未披露 定期报告 2015-06-30
2015-05-11 8574.85 未披露 定期报告 2015-03-31
2015-03-16 8558.69 未披露
更多>>
from December 31, 2013 to December 31, 2014 Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants Stock-based compensation expense
2014-12-31
2014-11-07 8533.75 未披露 定期报告 2014-09-30
2014-08-07 8520.66 未披露 定期报告 2014-06-30
2014-05-12 8505.23 未披露 定期报告 2014-03-31
2014-03-17 8469.69 未披露 定期报告 2014-03-07
2014-03-17 8463.82 未披露
更多>>
from December 31, 2012 to December 31, 2013 Issuance of common stock, May 2013 financing Issuance of common stock, November 2013 financing Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants
2013-12-31
2014-02-07 8074.90 未披露 定期报告 2013-11-05
2013-11-12 5492.54 未披露 定期报告 2013-09-30
2013-08-08 5478.81 未披露 定期报告 2013-06-30
2013-04-15 4376.47 未披露 定期报告 2013-04-08
2013-03-15 4366.02 未披露 定期报告 2013-03-01
2013-03-15 4365.27 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common stock, March 2012 financing Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants
2012-12-31
2012-11-14 4351.81 未披露 定期报告 2012-11-02
2012-11-14 4351.80 未披露 定期报告 2012-09-30
2012-07-23 4344.09 未披露 定期报告 2012-07-16
2012-08-14 4344.10 未披露 定期报告 2012-06-30
2012-05-15 4337.16 未披露 定期报告 2012-05-04
2012-05-15 4336.10 未披露 定期报告 2012-03-31
2012-03-30 4330.79 未披露 定期报告 2012-03-21
2012-03-30 2458.20 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Issuance of common stock, restricted stock awards Issuance of common stock, 401(k) employer match Issuance of common stock, February 2011 financing Issuance of common stock, CEFF financings
2011-12-31
2011-11-14 2449.95 未披露 定期报告 2011-11-08
2011-11-14 2429.90 未披露 定期报告 2011-09-30
2011-08-15 2423.49 未披露 定期报告 2011-08-05
2011-08-15 2423.50 未披露 定期报告 2011-06-30
2011-05-13 2417.85 未披露 定期报告 2011-05-02
2011-05-13 2411.50 未披露 定期报告 2011-03-31
2011-03-31 2411.52 未披露 定期报告 2011-03-15
2011-03-31 1380.10 未披露
更多>>
from December 31, 2009 to December 31, 2010 Issuance of common stock, restricted stock awards Issuance of common stock, 401(k) employer match Issuance of common stock, February 2010 financing Issuance of common stock, April 2010 financing Issuance of common stock, October 2010 financing Issuance of common stock, June 2010 financing Issuance of common stock, CEFF financings On December 28, 2010, we implemented a 1-for-15 reverse stock split
2010-12-31
2010-12-27 1377.69 未披露
更多>>
1 for 15 split of it”s common stock
2010-12-28
2010-11-15 20665.28 未披露 定期报告 2010-11-12
2010-11-15 19887.30 未披露 定期报告 2010-09-30
2010-08-09 19407.56 未披露 定期报告 2010-08-05
2010-08-09 19407.60 未披露 定期报告 2010-06-30
2010-05-10 15806.48 未披露 定期报告 2010-05-01
2010-05-10 15401.20 未披露 定期报告 2010-03-31
From March 31, 2025 to June 30, 2025 Exercise of common stock warrants Series C preferred stock conversions Issuance of common stock, ELOC
From December 31, 2024 to March 31, 2025 Series C preferred stock conversions Issuance of common stock, ELOC Issuance of common stock, equity consideration in debt extinguishment Exercise of common stock warrants
a 1-for-50 reverse stock split of the outstanding shares of the Company’s common stock.
From June 30, 2024 to September 30, 2024 Issuance of Series C preferred stock for cash proceeds, net of issuance costs of $172 Redemptions of Series C preferred stock Exchange of Series B preferred stock ELOC sales, net of issuance costs of $156 Issuance of Series C preferred stock to extinguish debt Conversions of Series C preferred stock
From March 31, 2024 to June 30, 2024 Reverse split adjustments - fractional share round ups
1-for-18 reverse stock split of its issued and outstanding common stock
From December 31,2022 to December 31,2023 Vesting of restricted stock units Exercise of common stock warrants, net of expenses of $276 Reverse split adjustments - fractional share round ups Issuance of common stock and common stock warrants, net of issuance costs of $1,630 Issuance of common stock, ATM Program, net of issuance costs of $23
From December 31, 2022 to March 31, 2023 Exercise of common stock warrants, net of expenses Vesting of restricted stock units Reverse split adjustments - fractional share round ups Redemption of Series A Preferred Stock
On February 23, 2023, Windtree Therapeutics, Inc. (the “Company”) announced that it intends to effect a reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1 post-split share for every 50 pre-split shares.
From June 30, 2022 to September 30, 2022 Issuance of common stock, ATM Program, net of issuance costs
From March 31, 2022 to June 30, 2022 Issuance of common stock, ATM Program, net of issuance costs
From December 31, 2021 to March 31, 2022 Issuance of common stock, ATM Program, net of issuance costs
From December 31, 2020 to December 31, 2021 Issuance of common stock and common stock warrants, net of issuance costs Issuance of common stock, ATM Program, net of issuance costs
From March 31, 2021 to June 30, 2021 Issuance of common stock, ATM Program
From December 31, 2020 to March 31, 2021 Issuance of common stock, ATM Program Issuance of common stock and common stock warrants, net of issuance costs
1.Common stock offered by the company 9,230,500 shares. 2.The number of shares of common stock that will be outstanding after this offering is based on 17,026,565 shares of common stock outstanding as of March 19, 2021.
From June 30, 2020 to September 30, 2020 Vesting of restricted stock units Exercise of common stock warrants
from March 31, 2020 to June 30, 2020 Issuance of common stock and common stock warrants, net of issuance costs
1.We are offering 2,758,620 units. Each unit will consist of one share of our common stock and a warrant to purchase one share of our common stock.
from December 31, 2015 to December 31, 2016 Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match
From December 31, 2014 to January 25, 2016 Issuance of common stock, July 2015 financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Stock-based compensation expense The accompanying consolidated financial statements reflect a 1-for-14 reverse split of our common stock and a change in the number of shares of common stock authorized for issuance under our Amended and Restated Certificate of Incorporation, as amended (Certificate of Incorporation), that was approved by our Board of Directors and stockholders and made effective on January 22, 2016.
from December 31, 2013 to December 31, 2014 Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants Stock-based compensation expense
from December 31, 2012 to December 31, 2013 Issuance of common stock, May 2013 financing Issuance of common stock, November 2013 financing Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants
from December 31, 2011 to December 31, 2012 Issuance of common stock, March 2012 financing Issuance of common stock, ATM financing Issuance of common stock, 401(k) Plan employer match Exercise of common stock warrants Exercise of stock options for cash Issuance of common stock, consultants
from Dec 31,2010 to Dec 31,2011 Issuance of common stock, restricted stock awards Issuance of common stock, 401(k) employer match Issuance of common stock, February 2011 financing Issuance of common stock, CEFF financings
from December 31, 2009 to December 31, 2010 Issuance of common stock, restricted stock awards Issuance of common stock, 401(k) employer match Issuance of common stock, February 2010 financing Issuance of common stock, April 2010 financing Issuance of common stock, October 2010 financing Issuance of common stock, June 2010 financing Issuance of common stock, CEFF financings On December 28, 2010, we implemented a 1-for-15 reverse stock split
1 for 15 split of it”s common stock
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。